Bartolini RM, Kidwell DJ, Creed-Kanashiro HM, Díaz-Otoya MM, Mosqueira-Lovón NR, Penny ME, Winkler JL, LaMontagne DS, Bingham A

Idioma: Español
Referencias bibliográficas: 37
Paginas: 226-233
Archivo PDF: 138.49 Kb.

RESUMEN

Objetivo. Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. Material y métodos. Investigación formativa usando técnicas cualitativas y cuantitativas. Los participantes incluyeron niños, padres, líderes, funcionarios del sector salud y educación, y diseñadores de políticas. Resultados. Generalmente se apoya la introducción de la vacuna contra el VPH, dado que se aprecian los beneficios de la vacunación y se desea prevenir el cáncer. En la comunidad se encontraron preocupaciones sobre seguridad, confianza y calidad de atención. El sistema de inmunizaciones en el Perú es eficiente y tiene la capacidad para incluir la vacuna contra el VPH. Conclusiones. La investigación formativa permite comprender elementos clave que ayudan a diseñar un programa efectivo para la introducción de la vacuna contra el VPH.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Parkin DM, Almonte M, Bruni L, Clifford C, Curado M, Pineros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008;26(Suppl 11):L1-L15.

2. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645-1651.

3. Ling M, Kanayama M, Roden R, Wu TC. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers. J Biomed Sci 2000;7(5):341-356.

4. Hildesheim A, Markowitz L, Avila MH, Franceschi S. Research needs following initial licensure of virus-like particle HPV vaccines. Vaccine 2006;24(Suppl 3):227-232.

5. Burchell AN, Winer RL, de Sanjose S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24(Suppl 3):52-61.

6. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. HPV typedistribution in women with and without cervical neoplastic diseases. Vaccine 2006;24(Suppl 3):26-34.

7. World Health Organization (WHO), Department of Immunization, Vaccines and Biologicals. Vaccine Introduction Guidelines: Adding a Vaccine to a National Immunization Programme: Decision and Implementation. Geneva (Switzerland): WHO, 2005.

8. Pan American Health Organization (PAHO). Regional Strategy and Plan of Action for Cervical Cancer Prevention and Control. Washington (DC): PAHO, 2008.

9. Correa P. The war against cervical cancer in Latin America and the Caribbean. Triumph of the scientists. Challenge for the community. Vaccine 2008;26(Suppl 11):iii-iv.

10. Newes G, Helitzer DL, Caulfield LE, Borwn KH. Theory and practice: applying the ecological model to formative research for a WIC training program in New York State. Health Educ Res 2000;15(3):283-291.

11. Wittet S. Cervical cancer vaccine project [fact sheet]. Seattle (WA): PATH, 2006.

12. Bingham A, Janmohamed A, Bartolini R, Creed-Kanashiro H, Katahoire A, Khan I, et al. An approach to formative research in HPV vaccine introduction planning in low-resource settings. The Open Vaccine Journal 2009;2:1-16.

13. Green LM, Kreuter MW. Health Promotion Planning: An Educational and Ecological Approach. 3rd ed. Mountain View (CA): Mayfield, 1999.

14. Kuzel AJ. Sampling in qualitative inquiry. In Crabtree BF, Miller WL, eds. Doing Qualitative Research. Newbury Park, CA: Sage Publications, 1992: 33-46.

15. PATH, Instituto de Investigación Nutricional (IIN). Shaping a Strategy to Introduce HPV Vaccines in Peru: Formative Research Results from the HPV Vaccines: Evidence For Impact Project. Seattle (WA): PATH, 2009.

16. Miles MB, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks (CA): Sage Publications, 1994.

17. Gilchrist VJ. Key informant interviews. In Crabtree BF, Miller WL, eds. Doing Qualitative Research. Newbury Park, CA: Sage Publications, 1992: 70-89.

18. Creed-Kanashiro HM, Bartolini RM, Fukumoto MN, Uribe TG, Robert RC, Bentley ME. Formative research to develop a nutrition education intervention to improve dietary iron intake among women and adolescent girls through community kitchens in Lima, Peru. J Nutr 2003;133(11 Suppl 2):3987S-3991S.

19. World Health Organization (WHO). Training for Mid-Level Managers: Cold Chain, Vaccines and Safe-Injection Equipment Management. Geneva (Switzerland): WHO, 2008.

20. United States Agency for International Development (USAID). Immunization Essentials: A Practical Field Guide. Washington (DC): USAID, 2003.

21. Biellik R, Levin C, Mugisha E, LaMontagne DS, Bingham A, Kaipilyawar S, et al. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine 2009;27(44):6203- 6209.

22. Andrus JK, Lewis MJ, Goldie SJ, García PJ, Winkler JL, Ruiz-Matus C, et al. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean. Vaccine 2008;26(Suppl 11):L80-L87.

23. Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano- Ponce E, Lewis-Bell K, et al. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine 2008;26(Suppl 11):L73-L79.

24. World Health Organization (WHO), United Nations Population Fund. Preparing for the Introduction of HPV Vaccines: Policy and Programme Guidance for Countries. Geneva (Switzerland): WHO, 2006.

25. Instituto Nacional de Estadística e Informática (INEI). Compendio Estadístico 2006. Lima (Peru): INEI, 2006.

26. Kaljee LM, Pack R, Pach A, Nyamete A, Stanton BF. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. J Health Popul Nutr 2004;22(3):293-303.

27. Jheeta M, Jewell J. Childhood vaccination in Africa and Asia: the effects of parents’ knowledge and attitudes. Bull World Health Organ 2008;86(6):419.

28. Garcia SG, Becker D, Tatum C, Aldrich T, Fernandez CA. Linking cervical cancer to the human papillomavairus: findings from a qualitative study with Mexican women. Health Care Women Int 2007;28(2):192-205.

29. Moreira Jr. ED, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil; implications for health education and prevention. Int J Gynecol Cancer 2006;16(2):599-603.

30. Agurto I, Bishop A, Sánchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med 2004;39(1):91-98.

31. Bingham A, Bishop A, Coffey P,Winkler J, Bradley J, Dzuba I, et al. Factors affecting utilization of cervical cancer prevention services in lowresource settings. Salud Publica Mex 2003;45(Suppl 3):S408-S416.

32. Pan American Health Organization (PAHO). Youth: Choices and Change; Promoting Health Behaviors in Adolescents. Washington (DC): PAHO, 2005.

33. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 2006;24(Suppl 3):201-209.

34. Kahn JA, Burk RD. Papillomavirus vaccines in perspective. The Lancet 2007;369(9580):2135-2137.

35. Mays RM, Sturm LM, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004;58(7):1405-1413.

36. Almonte M, Albero G, Molano M, Carcamo C, Garcia PJ, Perez GI. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008;26(Suppl 11):L16-L36.

37. Luciani S, Andrus JK. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean. Reprod Health Matters 2008;16(32):59-66.